At Ketavita Wellness Clinic, we offer specialized ketamine therapy for social anxiety disorder (social phobia) that hasn’t responded adequately to traditional treatments. When conventional medications and cognitive behavioral therapy haven’t provided sufficient relief from the intense fear of social situations and judgment by others, our IV ketamine treatments offer a different approach through glutamate modulation that works rapidly to reduce social anxiety symptoms.
Located in Wyckoff, New Jersey, our clinic provides evidence-based care from experienced medical professionals who understand how debilitating social phobia can be. We create personalized treatment plans designed to help you achieve meaningful symptom reduction, improving your ability to engage in social situations, work environments, and daily activities that previously felt overwhelming.
Every treatment journey begins with a comprehensive evaluation where we review your social anxiety symptoms including specific situations that trigger fear, physical symptoms you experience in social situations, avoidance behaviors and their impact on your life, when symptoms began and how they’ve progressed, and previous treatments you’ve tried including medications and therapy approaches. We work closely with you throughout treatment, monitoring your response and adjusting protocols to optimize outcomes.
Social anxiety disorder, also called social phobia, is characterized by marked and persistent fear of social or performance situations in which embarrassment or negative evaluation might occur. This condition affects approximately 12% of adults and typically begins in adolescence, causing significant impairment in academic, occupational, and social functioning throughout life.
The fear in social phobia goes far beyond ordinary shyness or nervousness. People with social phobia experience intense anxiety about being scrutinized, judged, or evaluated negatively by others in social settings. Common feared situations include speaking in public or in meetings, eating or drinking in front of others, writing while being watched, meeting new people or attending social gatherings, being the center of attention, and performing in front of others.
These social fears are accompanied by significant physical symptoms including rapid heartbeat, sweating, trembling or shaking, blushing, upset stomach or nausea, difficulty breathing, dizziness or lightheadedness, and muscle tension. The anxiety is often so intense that people recognize their fear is excessive or unreasonable, yet feel powerless to control it when faced with feared situations.
Avoidance becomes a central feature of social phobia. To prevent the intense discomfort of social situations, people increasingly avoid circumstances that trigger their anxiety. This avoidance provides temporary relief but maintains and worsens the condition over time. Many people with social phobia find their lives progressively restricted as they avoid more situations, leading to isolation, missed opportunities for career advancement, strained relationships, and reduced quality of life.
Social phobia often occurs alongside other conditions. Depression is common, as the isolation and life restrictions caused by social anxiety contribute to low mood. Many people also experience generalized anxiety disorder, panic attacks, or substance use disorders—sometimes using alcohol or other substances to cope with social situations. The combination of social phobia with other conditions makes treatment more complex and increases overall impairment.
Treatment-resistant social phobia occurs when you haven’t achieved adequate symptom control despite receiving evidence-based first-line treatments. This typically means you’ve tried at least one SSRI medication (such as sertraline or paroxetine) at maximum tolerated dose for adequate duration (typically 12 weeks), completed or attempted cognitive behavioral therapy with exposure components with a qualified therapist, or tried combination treatment of medication plus CBT without satisfactory improvement in your ability to function in social situations.
Research indicates that while first-line treatments help many people with social phobia, significant numbers don’t achieve adequate relief. If you’ve tried multiple SSRIs or SNRIs without success, completed CBT with exposure exercises but continue to have intense social anxiety, experienced intolerable side effects from medications that prevented adequate trials, or remain significantly impaired in work, relationships, or daily activities due to social fear despite treatment, you likely have treatment-resistant social phobia.
Treatment resistance in social phobia doesn’t mean your condition is untreatable—it means your symptoms may require interventions targeting different neurobiological mechanisms. While standard medications primarily work through serotonin systems, emerging research suggests glutamate neurotransmission plays an important role in fear learning and social anxiety. Ketamine acts as an NMDA receptor antagonist affecting glutamate activity, offering a fundamentally different therapeutic approach.
Living with treatment-resistant social phobia is isolating and demoralizing. The constant fear of negative evaluation, avoidance of social situations, and physical anxiety symptoms restrict your life opportunities. Career advancement becomes difficult when you can’t participate fully in meetings or presentations. Relationships suffer when social gatherings feel impossible. The chronic nature of these limitations can lead to hopelessness about ever feeling comfortable around others. Specialized treatments like ketamine therapy provide new hope when conventional approaches haven’t worked.
Ketavita Wellness Clinic offers IV ketamine therapy for treatment-resistant social anxiety disorder. IV ketamine delivers ketamine through intravenous infusion over approximately 40 minutes, allowing precise dosing and continuous monitoring throughout treatment. Research indicates ketamine can provide rapid reduction in social anxiety symptoms, with improvements often emerging within hours to days rather than the 8-12 weeks typically required for SSRI medications.
Ketamine works through NMDA receptor antagonism, modulating glutamate neurotransmission in brain regions involved in fear learning, social cognition, and emotional regulation. During your consultation, we’ll discuss whether IV ketamine therapy is appropriate for your specific presentation of social anxiety.
Ketamine therapy for social phobia represents an off-label application, meaning it’s not FDA-approved specifically for social anxiety disorder. However, controlled research trials demonstrate significant efficacy for reducing social anxiety symptoms, particularly when conventional treatments have failed to provide adequate relief.
Ketamine functions as a noncompetitive NMDA receptor antagonist, rapidly modulating glutamate neurotransmission in the brain. Glutamate is the primary excitatory neurotransmitter and plays a critical role in learning, memory formation, and emotional processing—all systems involved in the development and maintenance of social anxiety.
Social phobia involves learned fear responses to social situations. Through negative experiences or perceived judgment, the brain forms strong associations between social contexts and threat. Research shows that people with social anxiety disorder have altered activity in brain regions responsible for processing social information, detecting threats, and regulating emotional responses, including the amygdala, prefrontal cortex, and anterior cingulate cortex.
By blocking NMDA receptors, ketamine rapidly increases glutamate signaling through alternative pathways and promotes neuroplasticity—the brain’s ability to form new neural connections. This may help modify overly strong fear associations with social situations and facilitate the formation of new, less threatening interpretations of social interactions. Ketamine’s neuroplastic effects may also help restore normal function in brain circuits responsible for social cognition and emotional regulation.
The rapid onset of ketamine’s anxiolytic effects distinguishes it from conventional social phobia medications. While traditional SSRIs require 8-12 weeks of daily use to achieve maximum benefit, ketamine research shows symptom improvement can occur within hours after administration, with effects persisting for days to weeks. This quick action may be particularly valuable for individuals with severe social phobia causing significant functional impairment in work or relationships.
Importantly, research suggests ketamine may create a window of reduced anxiety that allows people to engage more effectively in social activities. When social fear temporarily decreases, increased exposure to social situations can function as natural exposure therapy, potentially maintaining and enhancing ketamine’s anxiolytic effects. This highlights the potential value of combining ketamine with ongoing cognitive behavioral therapy.
Your social phobia treatment journey at Ketavita begins with a thorough evaluation. We’ll discuss your social anxiety symptoms including specific social situations you fear most, physical symptoms you experience when anxious, avoidance behaviors and how they limit your life, when symptoms began and patterns you’ve noticed, and impact on work, relationships, and daily functioning.
We’ll also review your treatment history in detail: all medications tried with their doses and duration, your experience with cognitive behavioral therapy including exposure exercises, response to each treatment attempt, any side effects experienced, and current medications you’re taking. This comprehensive assessment helps us determine if ketamine therapy is appropriate for your social phobia and develop the most effective treatment approach.
For IV ketamine therapy, treatment typically involves a series of infusions over several weeks. During each session, you’ll receive your ketamine infusion while resting in a private, comfortable treatment room. We monitor your vital signs continuously throughout the 40-minute infusion. You may experience mild dissociative effects during treatment—feelings of detachment or altered perception—but these are temporary and resolve within 1-2 hours.
After each treatment session, you’ll spend additional time in our office for recovery and monitoring before leaving. You cannot drive for 24 hours after ketamine treatment and must bring someone to drive you home. Most patients tolerate ketamine well, with common side effects including temporary dissociation, mild nausea, slight blood pressure elevation during infusion, and temporary dizziness.
Response to ketamine therapy for social phobia varies among individuals. Research shows many patients experience significant symptom reduction within the first two weeks following ketamine treatment. Studies demonstrate that approximately one-third of patients meet response criteria (35% or greater reduction in social anxiety symptoms) within two weeks of treatment. Some patients report the effects are more durable than those observed with ketamine treatment for depression, possibly because reduced social anxiety enables increased social engagement that reinforces the therapeutic effects. We use standardized social anxiety assessment tools like the Liebowitz Social Anxiety Scale to track your progress and adjust treatment based on your response.
Ketamine therapy for social phobia may be appropriate if you’ve struggled with persistent symptoms despite conventional treatment attempts. You may be a candidate if you’ve tried at least one SSRI medication (like sertraline or paroxetine) at maximum tolerated dose for adequate duration without sufficient relief, completed or attempted cognitive behavioral therapy with exposure components without adequate benefit, found that combination treatment of medication plus CBT hasn’t provided satisfactory symptom control, or continue to have intense fear of social situations that significantly impairs your work, relationships, or daily functioning despite treatment.
Good candidates for ketamine therapy are adults with diagnosed social anxiety disorder who remain significantly symptomatic despite appropriate trials of first-line treatments. Research on ketamine for social phobia has focused on individuals with marked fear across multiple social situations (generalized social anxiety disorder).
Certain factors may affect treatment suitability. During evaluation, we review cardiovascular health (ketamine temporarily raises blood pressure), history of psychosis or other psychiatric conditions, substance use history particularly involving alcohol used to cope with social situations, and any medications that might interact with ketamine. Your complete medical and psychiatric history helps ensure safe, appropriate treatment.
Research on ketamine for social phobia is more limited than for depression or PTSD, though controlled trials demonstrate significant benefit. We discuss current research findings transparently during consultation so you can make fully informed treatment decisions. It’s worth noting that research on ketamine for other types of phobias (specific phobias like fear of heights, animals, or flying) is very limited, and our treatment protocols focus on social anxiety disorder where the evidence base is stronger.
Our ketamine protocols for social phobia are informed by research demonstrating rapid anxiolytic effects. Randomized controlled trials show that ketamine significantly reduces social anxiety symptom scores on measures like the Liebowitz Social Anxiety Scale, with response rates of approximately 33% compared to 0% for placebo within two weeks of treatment. Research also demonstrates dose-response relationships, with higher ketamine doses (≥0.5 mg/kg) associated with greater anxiety reduction.
Safety is paramount in all our treatments. Ketamine has been used safely in medical settings for decades, and we follow established safety protocols for subanesthetic dosing in psychiatric applications. All treatments are administered by licensed medical professionals with appropriate training, monitoring equipment, and emergency protocols.
We recognize that effective social phobia management typically requires comprehensive treatment. While ketamine can provide rapid symptom relief, we strongly encourage continued engagement with cognitive behavioral therapy, particularly exposure-based approaches, and appropriate medication management when indicated. Ketamine may be particularly effective when combined with therapy, as reduced anxiety may help you engage more successfully in exposure exercises and social situations.
Research suggests that the anxiolytic effects of ketamine might be maintained and enhanced through increased social engagement following treatment. When anxiety temporarily decreases, participating in more social activities can function as natural exposure therapy, potentially prolonging ketamine’s benefits. We encourage patients to gradually increase social engagement as symptoms improve.
Patient education is essential to our approach. We ensure you understand how ketamine works differently from SSRIs, what the research shows about efficacy for social anxiety specifically, realistic expectations for symptom improvement and duration of effects, potential side effects or risks, and how ketamine fits into comprehensive social phobia treatment. Informed patients are better positioned to achieve optimal outcomes.
Ketamine therapy for social phobia is typically not covered by insurance as it represents off-label use. We provide transparent pricing information during your consultation so you can make informed decisions about treatment.
IV ketamine therapy for social anxiety disorder is $395 per session. A typical initial treatment series involves 6-8 infusions over 2-4 weeks, with maintenance sessions scheduled as needed based on symptom recurrence. The total investment depends on how many sessions you require and whether ongoing maintenance is necessary to maintain benefits. Research suggests effects can be relatively durable, with some patients showing sustained benefits for weeks following treatment series.
We understand that cost is an important consideration, especially after already trying multiple treatments without success. However, many patients with treatment-resistant social phobia find that even significant symptom reduction—decreased fear in social situations, reduced avoidance behaviors, improved work performance and relationships—substantially improves their quality of life and opportunities, justifying the investment in treatment.
While insurance typically doesn’t cover ketamine therapy for social phobia, we can provide receipts and clinical documentation that you may submit to your insurance company for possible out-of-network reimbursement. Coverage decisions are made by individual insurance companies based on their policies.
If you’ve been struggling with social anxiety disorder despite trying conventional treatments, ketamine therapy at Ketavita Wellness Clinic may offer new hope. Our evidence-based approach provides rapid symptom relief through glutamate modulation that works differently than standard social phobia medications.
Schedule a consultation to discuss your social anxiety symptoms and their impact on your life, explore whether ketamine therapy is appropriate for your situation, and develop a personalized treatment plan designed to help you reclaim your ability to engage comfortably in social situations.
Living with treatment-resistant social phobia is isolating and limiting, but you don’t have to accept persistent fear of social situations. Contact us today to learn how ketamine therapy can help you achieve the relief and confidence you’ve been seeking.
Research demonstrates significant social anxiety reduction with ketamine treatment. Controlled trials show that approximately 33% of patients meet response criteria (≥35% symptom reduction) within two weeks of ketamine infusion, compared to 0% for placebo. Studies also show dose-response relationships, with higher ketamine doses associated with greater symptom improvement.
Many patients experience symptom improvement within hours to days after ketamine administration. Research shows significant anxiety reduction measurable at 3 hours post-infusion and continuing through the first two weeks. This rapid onset distinguishes ketamine from SSRIs that require 8-12 weeks to reach full effect.
Duration of benefit varies among individuals. Research suggests effects may be relatively durable for social anxiety, with some studies showing sustained benefits weeks after treatment. Interestingly, some research indicates effects might be maintained longer for social anxiety than depression, possibly because reduced anxiety allows increased social engagement that reinforces therapeutic benefits.
Yes, in most cases. Many patients receive ketamine therapy while continuing their existing medication regimen. We’ll review all your current medications during consultation to ensure there are no contraindications. Never discontinue medications without consulting your prescribing physician.
Yes, we strongly encourage continued engagement with cognitive behavioral therapy, particularly exposure-based approaches. Research suggests ketamine’s anxiety-reducing effects might help you engage more successfully in exposure exercises and social situations. The combination may be more effective than ketamine alone.
No. Ketamine is not a cure for social anxiety disorder. It’s a treatment that can provide significant symptom relief, potentially creating a window of reduced anxiety that allows you to engage more effectively in therapy and social activities. Social phobia is typically a chronic condition requiring ongoing management, though many people achieve substantial improvement with appropriate treatment.
Research on ketamine for phobias has focused primarily on social anxiety disorder (social phobia). Evidence for specific phobias like fear of heights, animals, or flying is very limited. Our treatment protocols focus on social anxiety disorder where the research base is most established.
The most common side effects are temporary and occur during or shortly after treatment: dissociative feelings, mild nausea, temporary blood pressure elevation, and dizziness. These effects typically resolve within 1-2 hours. Serious side effects are rare when ketamine is administered properly in medical settings by trained professionals.
Mental Health Conditions
Conditions Treated
365 Franklin Avenue, Wyckoff, NJ 07481